nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—lung cancer—thyroid cancer	0.758	1	CtDrD
Vinorelbine—ABCB1—Sorafenib—thyroid cancer	0.00827	0.197	CbGbCtD
Vinorelbine—CYP3A4—Vandetanib—thyroid cancer	0.00822	0.196	CbGbCtD
Vinorelbine—CYP2D6—Sorafenib—thyroid cancer	0.00779	0.186	CbGbCtD
Vinorelbine—ABCB1—Doxorubicin—thyroid cancer	0.00502	0.12	CbGbCtD
Vinorelbine—CYP3A4—Sorafenib—thyroid cancer	0.00495	0.118	CbGbCtD
Vinorelbine—CYP2D6—Doxorubicin—thyroid cancer	0.00473	0.113	CbGbCtD
Vinorelbine—CYP3A4—Doxorubicin—thyroid cancer	0.00301	0.0716	CbGbCtD
Vinorelbine—TUBB3—Diurnally Regulated Genes with Circadian Orthologs—NCOA4—thyroid cancer	0.00233	0.0853	CbGpPWpGaD
Vinorelbine—TUBB8—head—thyroid cancer	0.00214	0.0667	CbGeAlD
Vinorelbine—TUBB3—Afatinib—Vandetanib—thyroid cancer	0.00188	0.417	CbGdCrCtD
Vinorelbine—TUBB2B—saliva-secreting gland—thyroid cancer	0.00159	0.0495	CbGeAlD
Vinorelbine—TUBB—saliva-secreting gland—thyroid cancer	0.0015	0.0468	CbGeAlD
Vinorelbine—TUBB2A—saliva-secreting gland—thyroid cancer	0.0015	0.0465	CbGeAlD
Vinorelbine—TUBB6—saliva-secreting gland—thyroid cancer	0.00148	0.0459	CbGeAlD
Vinorelbine—TUBB3—head—thyroid cancer	0.00146	0.0455	CbGeAlD
Vinorelbine—TUBB1—head—thyroid cancer	0.00143	0.0445	CbGeAlD
Vinorelbine—TUBB4B—saliva-secreting gland—thyroid cancer	0.00128	0.0399	CbGeAlD
Vinorelbine—TUBB2B—trachea—thyroid cancer	0.00123	0.0381	CbGeAlD
Vinorelbine—TUBB4B—Afatinib—Vandetanib—thyroid cancer	0.00116	0.258	CbGdCrCtD
Vinorelbine—TUBB—trachea—thyroid cancer	0.00116	0.0361	CbGeAlD
Vinorelbine—TUBB2A—trachea—thyroid cancer	0.00115	0.0359	CbGeAlD
Vinorelbine—TUBB6—trachea—thyroid cancer	0.00114	0.0354	CbGeAlD
Vinorelbine—TUBB—Loss of Nlp from mitotic centrosomes—PCM1—thyroid cancer	0.00106	0.039	CbGpPWpGaD
Vinorelbine—TUBB4A—thyroid gland—thyroid cancer	0.001	0.0312	CbGeAlD
Vinorelbine—TUBB4B—trachea—thyroid cancer	0.000989	0.0308	CbGeAlD
Vinorelbine—TUBB2B—thyroid gland—thyroid cancer	0.00097	0.0302	CbGeAlD
Vinorelbine—TUBB—Centrosome maturation—PCM1—thyroid cancer	0.000943	0.0345	CbGpPWpGaD
Vinorelbine—TUBB—thyroid gland—thyroid cancer	0.000918	0.0286	CbGeAlD
Vinorelbine—TUBB2A—thyroid gland—thyroid cancer	0.000913	0.0284	CbGeAlD
Vinorelbine—TUBB6—thyroid gland—thyroid cancer	0.0009	0.028	CbGeAlD
Vinorelbine—TUBB4A—head—thyroid cancer	0.00089	0.0277	CbGeAlD
Vinorelbine—TUBB6—Erlotinib—Vandetanib—thyroid cancer	0.000887	0.196	CbGdCrCtD
Vinorelbine—TUBB4A—Loss of Nlp from mitotic centrosomes—PCM1—thyroid cancer	0.000882	0.0323	CbGpPWpGaD
Vinorelbine—TUBB—Regulation of PLK1 Activity at G2/M Transition—PCM1—thyroid cancer	0.000866	0.0317	CbGpPWpGaD
Vinorelbine—TUBB2B—head—thyroid cancer	0.00086	0.0268	CbGeAlD
Vinorelbine—TUBB2A—head—thyroid cancer	0.00081	0.0252	CbGeAlD
Vinorelbine—TUBB4B—Loss of Nlp from mitotic centrosomes—PCM1—thyroid cancer	0.000807	0.0296	CbGpPWpGaD
Vinorelbine—TUBB6—head—thyroid cancer	0.000799	0.0249	CbGeAlD
Vinorelbine—TUBB4B—thyroid gland—thyroid cancer	0.000783	0.0244	CbGeAlD
Vinorelbine—TUBB4A—Centrosome maturation—PCM1—thyroid cancer	0.000781	0.0286	CbGpPWpGaD
Vinorelbine—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—PCM1—thyroid cancer	0.000717	0.0263	CbGpPWpGaD
Vinorelbine—TUBB4B—Centrosome maturation—PCM1—thyroid cancer	0.000715	0.0262	CbGpPWpGaD
Vinorelbine—TUBB4B—head—thyroid cancer	0.000694	0.0216	CbGeAlD
Vinorelbine—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—PCM1—thyroid cancer	0.000656	0.024	CbGpPWpGaD
Vinorelbine—TUBB—G2/M Transition—PCM1—thyroid cancer	0.00065	0.0238	CbGpPWpGaD
Vinorelbine—TUBB—Mitotic G2-G2/M phases—PCM1—thyroid cancer	0.000641	0.0235	CbGpPWpGaD
Vinorelbine—TUBB4A—lymph node—thyroid cancer	0.000623	0.0194	CbGeAlD
Vinorelbine—TUBB2B—lymph node—thyroid cancer	0.000602	0.0187	CbGeAlD
Vinorelbine—TUBB6—Afatinib—Vandetanib—thyroid cancer	0.00058	0.128	CbGdCrCtD
Vinorelbine—TUBB—lymph node—thyroid cancer	0.00057	0.0177	CbGeAlD
Vinorelbine—TUBB2A—lymph node—thyroid cancer	0.000567	0.0176	CbGeAlD
Vinorelbine—TUBB6—lymph node—thyroid cancer	0.000559	0.0174	CbGeAlD
Vinorelbine—TUBB4A—G2/M Transition—PCM1—thyroid cancer	0.000539	0.0197	CbGpPWpGaD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—PCM1—thyroid cancer	0.000531	0.0195	CbGpPWpGaD
Vinorelbine—TUBB4B—G2/M Transition—PCM1—thyroid cancer	0.000493	0.0181	CbGpPWpGaD
Vinorelbine—TUBB4B—lymph node—thyroid cancer	0.000486	0.0151	CbGeAlD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—PCM1—thyroid cancer	0.000486	0.0178	CbGpPWpGaD
Vinorelbine—TUBB—Loss of Nlp from mitotic centrosomes—CDK1—thyroid cancer	0.000441	0.0161	CbGpPWpGaD
Vinorelbine—TUBB—Centrosome maturation—CDK1—thyroid cancer	0.00039	0.0143	CbGpPWpGaD
Vinorelbine—TUBB4A—Loss of Nlp from mitotic centrosomes—CDK1—thyroid cancer	0.000365	0.0134	CbGpPWpGaD
Vinorelbine—TUBB—Regulation of PLK1 Activity at G2/M Transition—CDK1—thyroid cancer	0.000358	0.0131	CbGpPWpGaD
Vinorelbine—Cardiac disorder—Sorafenib—thyroid cancer	0.000349	0.00256	CcSEcCtD
Vinorelbine—Decreased appetite—Vandetanib—thyroid cancer	0.000345	0.00252	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000342	0.00251	CcSEcCtD
Vinorelbine—Fatigue—Vandetanib—thyroid cancer	0.000342	0.0025	CcSEcCtD
Vinorelbine—Angiopathy—Sorafenib—thyroid cancer	0.000341	0.0025	CcSEcCtD
Vinorelbine—Immune system disorder—Sorafenib—thyroid cancer	0.00034	0.00249	CcSEcCtD
Vinorelbine—Injection site pain—Epirubicin—thyroid cancer	0.000339	0.00249	CcSEcCtD
Vinorelbine—Mediastinal disorder—Sorafenib—thyroid cancer	0.000339	0.00248	CcSEcCtD
Vinorelbine—Constipation—Vandetanib—thyroid cancer	0.000339	0.00248	CcSEcCtD
Vinorelbine—Pain—Vandetanib—thyroid cancer	0.000339	0.00248	CcSEcCtD
Vinorelbine—Arrhythmia—Sorafenib—thyroid cancer	0.000336	0.00246	CcSEcCtD
Vinorelbine—TUBB4B—Loss of Nlp from mitotic centrosomes—CDK1—thyroid cancer	0.000334	0.0122	CbGpPWpGaD
Vinorelbine—Alopecia—Sorafenib—thyroid cancer	0.000333	0.00244	CcSEcCtD
Vinorelbine—Erythema—Sorafenib—thyroid cancer	0.000328	0.0024	CcSEcCtD
Vinorelbine—Malnutrition—Sorafenib—thyroid cancer	0.000328	0.0024	CcSEcCtD
Vinorelbine—Hyperaesthesia—Doxorubicin—thyroid cancer	0.000326	0.00239	CcSEcCtD
Vinorelbine—Necrosis—Doxorubicin—thyroid cancer	0.000326	0.00239	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000324	0.00237	CcSEcCtD
Vinorelbine—TUBB4A—Centrosome maturation—CDK1—thyroid cancer	0.000323	0.0119	CbGpPWpGaD
Vinorelbine—Extravasation—Epirubicin—thyroid cancer	0.000317	0.00233	CcSEcCtD
Vinorelbine—Vasodilation—Epirubicin—thyroid cancer	0.000315	0.00231	CcSEcCtD
Vinorelbine—Vasodilation procedure—Epirubicin—thyroid cancer	0.000315	0.00231	CcSEcCtD
Vinorelbine—Injection site pain—Doxorubicin—thyroid cancer	0.000314	0.0023	CcSEcCtD
Vinorelbine—Abdominal pain—Vandetanib—thyroid cancer	0.000313	0.0023	CcSEcCtD
Vinorelbine—Body temperature increased—Vandetanib—thyroid cancer	0.000313	0.0023	CcSEcCtD
Vinorelbine—Anaemia—Sorafenib—thyroid cancer	0.000303	0.00222	CcSEcCtD
Vinorelbine—Angioedema—Sorafenib—thyroid cancer	0.000299	0.00219	CcSEcCtD
Vinorelbine—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—CDK1—thyroid cancer	0.000297	0.0109	CbGpPWpGaD
Vinorelbine—TUBB4B—Centrosome maturation—CDK1—thyroid cancer	0.000296	0.0108	CbGpPWpGaD
Vinorelbine—Extravasation—Doxorubicin—thyroid cancer	0.000294	0.00215	CcSEcCtD
Vinorelbine—Leukopenia—Sorafenib—thyroid cancer	0.000293	0.00215	CcSEcCtD
Vinorelbine—Blood bilirubin increased—Epirubicin—thyroid cancer	0.000293	0.00215	CcSEcCtD
Vinorelbine—Vasodilation procedure—Doxorubicin—thyroid cancer	0.000292	0.00214	CcSEcCtD
Vinorelbine—Vasodilation—Doxorubicin—thyroid cancer	0.000292	0.00214	CcSEcCtD
Vinorelbine—Creatinine increased—Epirubicin—thyroid cancer	0.000291	0.00213	CcSEcCtD
Vinorelbine—ABCB1—trachea—thyroid cancer	0.000288	0.00895	CbGeAlD
Vinorelbine—Cough—Sorafenib—thyroid cancer	0.000286	0.00209	CcSEcCtD
Vinorelbine—Asthenia—Vandetanib—thyroid cancer	0.000284	0.00208	CcSEcCtD
Vinorelbine—Gait disturbance—Epirubicin—thyroid cancer	0.000284	0.00208	CcSEcCtD
Vinorelbine—Hypertension—Sorafenib—thyroid cancer	0.000283	0.00207	CcSEcCtD
Vinorelbine—CYP2D6—head—thyroid cancer	0.000281	0.00874	CbGeAlD
Vinorelbine—Pruritus—Vandetanib—thyroid cancer	0.00028	0.00205	CcSEcCtD
Vinorelbine—Myalgia—Sorafenib—thyroid cancer	0.000279	0.00204	CcSEcCtD
Vinorelbine—Arthralgia—Sorafenib—thyroid cancer	0.000279	0.00204	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000277	0.00203	CcSEcCtD
Vinorelbine—Pulmonary embolism—Epirubicin—thyroid cancer	0.000277	0.00203	CcSEcCtD
Vinorelbine—Injection site reaction—Epirubicin—thyroid cancer	0.000275	0.00202	CcSEcCtD
Vinorelbine—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—CDK1—thyroid cancer	0.000272	0.00995	CbGpPWpGaD
Vinorelbine—Diarrhoea—Vandetanib—thyroid cancer	0.000271	0.00199	CcSEcCtD
Vinorelbine—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.000271	0.00198	CcSEcCtD
Vinorelbine—TUBB2B—Orphan transporters—RXRA—thyroid cancer	0.000269	0.00987	CbGpPWpGaD
Vinorelbine—TUBB6—Orphan transporters—RXRA—thyroid cancer	0.000269	0.00987	CbGpPWpGaD
Vinorelbine—Creatinine increased—Doxorubicin—thyroid cancer	0.000269	0.00197	CcSEcCtD
Vinorelbine—TUBB—G2/M Transition—CDK1—thyroid cancer	0.000269	0.00986	CbGpPWpGaD
Vinorelbine—Anaphylactic shock—Sorafenib—thyroid cancer	0.000267	0.00196	CcSEcCtD
Vinorelbine—Infection—Sorafenib—thyroid cancer	0.000266	0.00195	CcSEcCtD
Vinorelbine—TUBB—Mitotic G2-G2/M phases—CDK1—thyroid cancer	0.000265	0.00972	CbGpPWpGaD
Vinorelbine—Skin exfoliation—Epirubicin—thyroid cancer	0.000264	0.00194	CcSEcCtD
Vinorelbine—Gait disturbance—Doxorubicin—thyroid cancer	0.000263	0.00192	CcSEcCtD
Vinorelbine—Nervous system disorder—Sorafenib—thyroid cancer	0.000262	0.00192	CcSEcCtD
Vinorelbine—Dizziness—Vandetanib—thyroid cancer	0.000262	0.00192	CcSEcCtD
Vinorelbine—Thrombocytopenia—Sorafenib—thyroid cancer	0.000262	0.00192	CcSEcCtD
Vinorelbine—TUBB3—Orphan transporters—RXRA—thyroid cancer	0.00026	0.00953	CbGpPWpGaD
Vinorelbine—Aplastic anaemia—Epirubicin—thyroid cancer	0.00026	0.00191	CcSEcCtD
Vinorelbine—Skin disorder—Sorafenib—thyroid cancer	0.00026	0.0019	CcSEcCtD
Vinorelbine—Pulmonary embolism—Doxorubicin—thyroid cancer	0.000256	0.00188	CcSEcCtD
Vinorelbine—Anorexia—Sorafenib—thyroid cancer	0.000255	0.00187	CcSEcCtD
Vinorelbine—Injection site reaction—Doxorubicin—thyroid cancer	0.000255	0.00187	CcSEcCtD
Vinorelbine—Oesophagitis—Epirubicin—thyroid cancer	0.000253	0.00185	CcSEcCtD
Vinorelbine—TUBB2A—Orphan transporters—RXRA—thyroid cancer	0.000252	0.00923	CbGpPWpGaD
Vinorelbine—Vomiting—Vandetanib—thyroid cancer	0.000252	0.00185	CcSEcCtD
Vinorelbine—Rash—Vandetanib—thyroid cancer	0.00025	0.00183	CcSEcCtD
Vinorelbine—Dermatitis—Vandetanib—thyroid cancer	0.00025	0.00183	CcSEcCtD
Vinorelbine—Headache—Vandetanib—thyroid cancer	0.000248	0.00182	CcSEcCtD
Vinorelbine—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000247	0.00904	CbGpPWpGaD
Vinorelbine—Pulmonary oedema—Epirubicin—thyroid cancer	0.000246	0.00181	CcSEcCtD
Vinorelbine—TUBB1—Orphan transporters—RXRA—thyroid cancer	0.000246	0.00903	CbGpPWpGaD
Vinorelbine—Skin exfoliation—Doxorubicin—thyroid cancer	0.000245	0.00179	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000244	0.00178	CcSEcCtD
Vinorelbine—Aplastic anaemia—Doxorubicin—thyroid cancer	0.000241	0.00176	CcSEcCtD
Vinorelbine—Sepsis—Epirubicin—thyroid cancer	0.00024	0.00176	CcSEcCtD
Vinorelbine—Dyspnoea—Sorafenib—thyroid cancer	0.000238	0.00175	CcSEcCtD
Vinorelbine—Nausea—Vandetanib—thyroid cancer	0.000235	0.00172	CcSEcCtD
Vinorelbine—Oesophagitis—Doxorubicin—thyroid cancer	0.000234	0.00172	CcSEcCtD
Vinorelbine—Phlebitis—Epirubicin—thyroid cancer	0.000233	0.00171	CcSEcCtD
Vinorelbine—Decreased appetite—Sorafenib—thyroid cancer	0.000232	0.0017	CcSEcCtD
Vinorelbine—Thrombophlebitis—Epirubicin—thyroid cancer	0.000232	0.0017	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000231	0.00169	CcSEcCtD
Vinorelbine—Fatigue—Sorafenib—thyroid cancer	0.00023	0.00169	CcSEcCtD
Vinorelbine—Constipation—Sorafenib—thyroid cancer	0.000229	0.00168	CcSEcCtD
Vinorelbine—Pain—Sorafenib—thyroid cancer	0.000229	0.00168	CcSEcCtD
Vinorelbine—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000228	0.00167	CcSEcCtD
Vinorelbine—ABCB1—thyroid gland—thyroid cancer	0.000228	0.00708	CbGeAlD
Vinorelbine—Hepatic failure—Epirubicin—thyroid cancer	0.000224	0.00164	CcSEcCtD
Vinorelbine—TUBB4A—G2/M Transition—CDK1—thyroid cancer	0.000223	0.00817	CbGpPWpGaD
Vinorelbine—Sepsis—Doxorubicin—thyroid cancer	0.000222	0.00163	CcSEcCtD
Vinorelbine—TUBB4A—Orphan transporters—RXRA—thyroid cancer	0.000221	0.0081	CbGpPWpGaD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—CDK1—thyroid cancer	0.00022	0.00806	CbGpPWpGaD
Vinorelbine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000219	0.0016	CcSEcCtD
Vinorelbine—Phlebitis—Doxorubicin—thyroid cancer	0.000216	0.00158	CcSEcCtD
Vinorelbine—Thrombophlebitis—Doxorubicin—thyroid cancer	0.000215	0.00157	CcSEcCtD
Vinorelbine—Urticaria—Sorafenib—thyroid cancer	0.000212	0.00156	CcSEcCtD
Vinorelbine—Abdominal pain—Sorafenib—thyroid cancer	0.000211	0.00155	CcSEcCtD
Vinorelbine—Body temperature increased—Sorafenib—thyroid cancer	0.000211	0.00155	CcSEcCtD
Vinorelbine—Dermatitis bullous—Epirubicin—thyroid cancer	0.00021	0.00154	CcSEcCtD
Vinorelbine—Hepatic failure—Doxorubicin—thyroid cancer	0.000207	0.00152	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.000207	0.00758	CbGpPWpGaD
Vinorelbine—Cardiac failure—Epirubicin—thyroid cancer	0.000206	0.00151	CcSEcCtD
Vinorelbine—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000205	0.0015	CcSEcCtD
Vinorelbine—Lethargy—Epirubicin—thyroid cancer	0.000205	0.0015	CcSEcCtD
Vinorelbine—TUBB4B—G2/M Transition—CDK1—thyroid cancer	0.000204	0.00747	CbGpPWpGaD
Vinorelbine—TUBB4B—Orphan transporters—RXRA—thyroid cancer	0.000202	0.00741	CbGpPWpGaD
Vinorelbine—ABCB1—head—thyroid cancer	0.000202	0.00628	CbGeAlD
Vinorelbine—Hyponatraemia—Epirubicin—thyroid cancer	0.000202	0.00148	CcSEcCtD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—CDK1—thyroid cancer	0.000201	0.00737	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Sorafenib—thyroid cancer	0.000197	0.00144	CcSEcCtD
Vinorelbine—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000195	0.00143	CcSEcCtD
Vinorelbine—Asthenia—Sorafenib—thyroid cancer	0.000192	0.00141	CcSEcCtD
Vinorelbine—Cardiac failure—Doxorubicin—thyroid cancer	0.000191	0.0014	CcSEcCtD
Vinorelbine—Lethargy—Doxorubicin—thyroid cancer	0.00019	0.00139	CcSEcCtD
Vinorelbine—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00019	0.00139	CcSEcCtD
Vinorelbine—Pruritus—Sorafenib—thyroid cancer	0.000189	0.00139	CcSEcCtD
Vinorelbine—Blood creatinine increased—Epirubicin—thyroid cancer	0.000188	0.00138	CcSEcCtD
Vinorelbine—Hyponatraemia—Doxorubicin—thyroid cancer	0.000187	0.00137	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—PCM1—thyroid cancer	0.000185	0.00678	CbGpPWpGaD
Vinorelbine—Diarrhoea—Sorafenib—thyroid cancer	0.000183	0.00134	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000181	0.00133	CcSEcCtD
Vinorelbine—Muscular weakness—Epirubicin—thyroid cancer	0.000177	0.0013	CcSEcCtD
Vinorelbine—Dizziness—Sorafenib—thyroid cancer	0.000177	0.0013	CcSEcCtD
Vinorelbine—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000174	0.00128	CcSEcCtD
Vinorelbine—Dysphagia—Epirubicin—thyroid cancer	0.000174	0.00127	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.000171	0.00628	CbGpPWpGaD
Vinorelbine—Pancreatitis—Epirubicin—thyroid cancer	0.00017	0.00125	CcSEcCtD
Vinorelbine—Vomiting—Sorafenib—thyroid cancer	0.00017	0.00125	CcSEcCtD
Vinorelbine—Angina pectoris—Epirubicin—thyroid cancer	0.000169	0.00124	CcSEcCtD
Vinorelbine—Rash—Sorafenib—thyroid cancer	0.000169	0.00124	CcSEcCtD
Vinorelbine—Dermatitis—Sorafenib—thyroid cancer	0.000168	0.00123	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000167	0.00123	CcSEcCtD
Vinorelbine—Headache—Sorafenib—thyroid cancer	0.000167	0.00123	CcSEcCtD
Vinorelbine—Pancytopenia—Epirubicin—thyroid cancer	0.000165	0.00121	CcSEcCtD
Vinorelbine—Muscular weakness—Doxorubicin—thyroid cancer	0.000164	0.0012	CcSEcCtD
Vinorelbine—TUBB2A—Signaling events mediated by HDAC Class III—TP53—thyroid cancer	0.000163	0.00598	CbGpPWpGaD
Vinorelbine—Neutropenia—Epirubicin—thyroid cancer	0.000162	0.00119	CcSEcCtD
Vinorelbine—Dysphagia—Doxorubicin—thyroid cancer	0.000161	0.00118	CcSEcCtD
Vinorelbine—Nausea—Sorafenib—thyroid cancer	0.000159	0.00116	CcSEcCtD
Vinorelbine—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000158	0.00578	CbGpPWpGaD
Vinorelbine—Pancreatitis—Doxorubicin—thyroid cancer	0.000158	0.00115	CcSEcCtD
Vinorelbine—Weight decreased—Epirubicin—thyroid cancer	0.000157	0.00115	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.000157	0.00574	CbGpPWpGaD
Vinorelbine—Angina pectoris—Doxorubicin—thyroid cancer	0.000157	0.00115	CcSEcCtD
Vinorelbine—Pneumonia—Epirubicin—thyroid cancer	0.000156	0.00114	CcSEcCtD
Vinorelbine—Infestation NOS—Epirubicin—thyroid cancer	0.000155	0.00114	CcSEcCtD
Vinorelbine—Infestation—Epirubicin—thyroid cancer	0.000155	0.00114	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—PCM1—thyroid cancer	0.000153	0.00561	CbGpPWpGaD
Vinorelbine—Pancytopenia—Doxorubicin—thyroid cancer	0.000153	0.00112	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000152	0.00111	CcSEcCtD
Vinorelbine—Stomatitis—Epirubicin—thyroid cancer	0.000151	0.00111	CcSEcCtD
Vinorelbine—Neutropenia—Doxorubicin—thyroid cancer	0.00015	0.0011	CcSEcCtD
Vinorelbine—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000148	0.00541	CbGpPWpGaD
Vinorelbine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000147	0.00107	CcSEcCtD
Vinorelbine—Weight decreased—Doxorubicin—thyroid cancer	0.000145	0.00107	CcSEcCtD
Vinorelbine—Agranulocytosis—Epirubicin—thyroid cancer	0.000145	0.00106	CcSEcCtD
Vinorelbine—Pneumonia—Doxorubicin—thyroid cancer	0.000144	0.00106	CcSEcCtD
Vinorelbine—Infestation—Doxorubicin—thyroid cancer	0.000143	0.00105	CcSEcCtD
Vinorelbine—Infestation NOS—Doxorubicin—thyroid cancer	0.000143	0.00105	CcSEcCtD
Vinorelbine—ABCB1—lymph node—thyroid cancer	0.000141	0.0044	CbGeAlD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000141	0.00515	CbGpPWpGaD
Vinorelbine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000141	0.00103	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—PCM1—thyroid cancer	0.00014	0.00514	CbGpPWpGaD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.00014	0.00513	CbGpPWpGaD
Vinorelbine—Stomatitis—Doxorubicin—thyroid cancer	0.00014	0.00102	CcSEcCtD
Vinorelbine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000138	0.00101	CcSEcCtD
Vinorelbine—Connective tissue disorder—Epirubicin—thyroid cancer	0.000137	0.001	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000136	0.000993	CcSEcCtD
Vinorelbine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000134	0.00098	CcSEcCtD
Vinorelbine—CYP2D6—Metapathway biotransformation—CHST14—thyroid cancer	0.000131	0.00481	CbGpPWpGaD
Vinorelbine—Flushing—Epirubicin—thyroid cancer	0.000129	0.000946	CcSEcCtD
Vinorelbine—Cardiac disorder—Epirubicin—thyroid cancer	0.000129	0.000946	CcSEcCtD
Vinorelbine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000128	0.000938	CcSEcCtD
Vinorelbine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000126	0.000926	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—TPR—thyroid cancer	0.000126	0.00463	CbGpPWpGaD
Vinorelbine—Angiopathy—Epirubicin—thyroid cancer	0.000126	0.000924	CcSEcCtD
Vinorelbine—Immune system disorder—Epirubicin—thyroid cancer	0.000126	0.00092	CcSEcCtD
Vinorelbine—Mediastinal disorder—Epirubicin—thyroid cancer	0.000125	0.000918	CcSEcCtD
Vinorelbine—Arrhythmia—Epirubicin—thyroid cancer	0.000124	0.00091	CcSEcCtD
Vinorelbine—Alopecia—Epirubicin—thyroid cancer	0.000123	0.0009	CcSEcCtD
Vinorelbine—Malnutrition—Epirubicin—thyroid cancer	0.000121	0.000887	CcSEcCtD
Vinorelbine—Erythema—Epirubicin—thyroid cancer	0.000121	0.000887	CcSEcCtD
Vinorelbine—Flushing—Doxorubicin—thyroid cancer	0.000119	0.000875	CcSEcCtD
Vinorelbine—Cardiac disorder—Doxorubicin—thyroid cancer	0.000119	0.000875	CcSEcCtD
Vinorelbine—Back pain—Epirubicin—thyroid cancer	0.000117	0.000858	CcSEcCtD
Vinorelbine—Angiopathy—Doxorubicin—thyroid cancer	0.000117	0.000855	CcSEcCtD
Vinorelbine—Immune system disorder—Doxorubicin—thyroid cancer	0.000116	0.000852	CcSEcCtD
Vinorelbine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000116	0.00085	CcSEcCtD
Vinorelbine—Arrhythmia—Doxorubicin—thyroid cancer	0.000115	0.000842	CcSEcCtD
Vinorelbine—Alopecia—Doxorubicin—thyroid cancer	0.000114	0.000833	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—TPR—thyroid cancer	0.000113	0.00414	CbGpPWpGaD
Vinorelbine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000112	0.000823	CcSEcCtD
Vinorelbine—Erythema—Doxorubicin—thyroid cancer	0.000112	0.000821	CcSEcCtD
Vinorelbine—Malnutrition—Doxorubicin—thyroid cancer	0.000112	0.000821	CcSEcCtD
Vinorelbine—Anaemia—Epirubicin—thyroid cancer	0.000112	0.00082	CcSEcCtD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.00011	0.00404	CbGpPWpGaD
Vinorelbine—Malaise—Epirubicin—thyroid cancer	0.000109	0.0008	CcSEcCtD
Vinorelbine—Vertigo—Epirubicin—thyroid cancer	0.000109	0.000797	CcSEcCtD
Vinorelbine—Leukopenia—Epirubicin—thyroid cancer	0.000108	0.000794	CcSEcCtD
Vinorelbine—Back pain—Doxorubicin—thyroid cancer	0.000108	0.000794	CcSEcCtD
Vinorelbine—Palpitations—Epirubicin—thyroid cancer	0.000107	0.000784	CcSEcCtD
Vinorelbine—Cough—Epirubicin—thyroid cancer	0.000106	0.000774	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—TPR—thyroid cancer	0.000105	0.00384	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—CP—thyroid cancer	0.000105	0.00383	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000105	0.00383	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000105	0.00383	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—CP—thyroid cancer	0.000105	0.00383	CbGpPWpGaD
Vinorelbine—Hypertension—Epirubicin—thyroid cancer	0.000105	0.000766	CcSEcCtD
Vinorelbine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000104	0.000761	CcSEcCtD
Vinorelbine—Anaemia—Doxorubicin—thyroid cancer	0.000104	0.000759	CcSEcCtD
Vinorelbine—Arthralgia—Epirubicin—thyroid cancer	0.000103	0.000755	CcSEcCtD
Vinorelbine—Myalgia—Epirubicin—thyroid cancer	0.000103	0.000755	CcSEcCtD
Vinorelbine—Chest pain—Epirubicin—thyroid cancer	0.000103	0.000755	CcSEcCtD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000103	0.00377	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000103	0.00377	CbGpPWpGaD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000102	0.00075	CcSEcCtD
Vinorelbine—Discomfort—Epirubicin—thyroid cancer	0.000102	0.000746	CcSEcCtD
Vinorelbine—Malaise—Doxorubicin—thyroid cancer	0.000101	0.00074	CcSEcCtD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000101	0.0037	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000101	0.0037	CbGpPWpGaD
Vinorelbine—Vertigo—Doxorubicin—thyroid cancer	0.000101	0.000737	CcSEcCtD
Vinorelbine—Leukopenia—Doxorubicin—thyroid cancer	0.0001	0.000735	CcSEcCtD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	9.94e-05	0.00364	CbGpPWpGaD
Vinorelbine—Palpitations—Doxorubicin—thyroid cancer	9.9e-05	0.000725	CcSEcCtD
Vinorelbine—Anaphylactic shock—Epirubicin—thyroid cancer	9.88e-05	0.000724	CcSEcCtD
Vinorelbine—Infection—Epirubicin—thyroid cancer	9.82e-05	0.000719	CcSEcCtD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—CP—thyroid cancer	9.78e-05	0.00358	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—TPR—thyroid cancer	9.78e-05	0.00358	CbGpPWpGaD
Vinorelbine—Cough—Doxorubicin—thyroid cancer	9.77e-05	0.000716	CcSEcCtD
Vinorelbine—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	9.73e-05	0.00356	CbGpPWpGaD
Vinorelbine—Nervous system disorder—Epirubicin—thyroid cancer	9.69e-05	0.00071	CcSEcCtD
Vinorelbine—Thrombocytopenia—Epirubicin—thyroid cancer	9.67e-05	0.000709	CcSEcCtD
Vinorelbine—Hypertension—Doxorubicin—thyroid cancer	9.67e-05	0.000709	CcSEcCtD
Vinorelbine—Tachycardia—Epirubicin—thyroid cancer	9.64e-05	0.000707	CcSEcCtD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	9.62e-05	0.00353	CbGpPWpGaD
Vinorelbine—Skin disorder—Epirubicin—thyroid cancer	9.6e-05	0.000703	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—TPR—thyroid cancer	9.58e-05	0.00351	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—CP—thyroid cancer	9.56e-05	0.0035	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—TPR—thyroid cancer	9.56e-05	0.0035	CbGpPWpGaD
Vinorelbine—Myalgia—Doxorubicin—thyroid cancer	9.54e-05	0.000699	CcSEcCtD
Vinorelbine—Chest pain—Doxorubicin—thyroid cancer	9.54e-05	0.000699	CcSEcCtD
Vinorelbine—Arthralgia—Doxorubicin—thyroid cancer	9.54e-05	0.000699	CcSEcCtD
Vinorelbine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	9.5e-05	0.00348	CbGpPWpGaD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	9.47e-05	0.000694	CcSEcCtD
Vinorelbine—Discomfort—Doxorubicin—thyroid cancer	9.42e-05	0.00069	CcSEcCtD
Vinorelbine—Anorexia—Epirubicin—thyroid cancer	9.42e-05	0.00069	CcSEcCtD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	9.41e-05	0.00345	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TPR—thyroid cancer	9.36e-05	0.00343	CbGpPWpGaD
Vinorelbine—Hypotension—Epirubicin—thyroid cancer	9.23e-05	0.000676	CcSEcCtD
Vinorelbine—Anaphylactic shock—Doxorubicin—thyroid cancer	9.14e-05	0.00067	CcSEcCtD
Vinorelbine—Infection—Doxorubicin—thyroid cancer	9.08e-05	0.000665	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	9e-05	0.00066	CcSEcCtD
Vinorelbine—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	9e-05	0.0033	CbGpPWpGaD
Vinorelbine—Nervous system disorder—Doxorubicin—thyroid cancer	8.97e-05	0.000657	CcSEcCtD
Vinorelbine—Thrombocytopenia—Doxorubicin—thyroid cancer	8.95e-05	0.000656	CcSEcCtD
Vinorelbine—Tachycardia—Doxorubicin—thyroid cancer	8.92e-05	0.000654	CcSEcCtD
Vinorelbine—Skin disorder—Doxorubicin—thyroid cancer	8.88e-05	0.000651	CcSEcCtD
Vinorelbine—Paraesthesia—Epirubicin—thyroid cancer	8.87e-05	0.00065	CcSEcCtD
Vinorelbine—Dyspnoea—Epirubicin—thyroid cancer	8.81e-05	0.000645	CcSEcCtD
Vinorelbine—Anorexia—Doxorubicin—thyroid cancer	8.71e-05	0.000638	CcSEcCtD
Vinorelbine—Decreased appetite—Epirubicin—thyroid cancer	8.59e-05	0.000629	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—TPR—thyroid cancer	8.59e-05	0.00315	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—CP—thyroid cancer	8.59e-05	0.00315	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	8.58e-05	0.00314	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TPR—thyroid cancer	8.56e-05	0.00314	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDK1—thyroid cancer	8.56e-05	0.00314	CbGpPWpGaD
Vinorelbine—Hypotension—Doxorubicin—thyroid cancer	8.54e-05	0.000626	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Epirubicin—thyroid cancer	8.53e-05	0.000625	CcSEcCtD
Vinorelbine—Fatigue—Epirubicin—thyroid cancer	8.52e-05	0.000624	CcSEcCtD
Vinorelbine—Pain—Epirubicin—thyroid cancer	8.45e-05	0.000619	CcSEcCtD
Vinorelbine—Constipation—Epirubicin—thyroid cancer	8.45e-05	0.000619	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.45e-05	0.0031	CbGpPWpGaD
Vinorelbine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	8.33e-05	0.00061	CcSEcCtD
Vinorelbine—Paraesthesia—Doxorubicin—thyroid cancer	8.21e-05	0.000601	CcSEcCtD
Vinorelbine—Dyspnoea—Doxorubicin—thyroid cancer	8.15e-05	0.000597	CcSEcCtD
Vinorelbine—Feeling abnormal—Epirubicin—thyroid cancer	8.14e-05	0.000597	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Epirubicin—thyroid cancer	8.08e-05	0.000592	CcSEcCtD
Vinorelbine—Decreased appetite—Doxorubicin—thyroid cancer	7.95e-05	0.000582	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	7.89e-05	0.000578	CcSEcCtD
Vinorelbine—Fatigue—Doxorubicin—thyroid cancer	7.88e-05	0.000577	CcSEcCtD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—CP—thyroid cancer	7.85e-05	0.00288	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—TPR—thyroid cancer	7.85e-05	0.00288	CbGpPWpGaD
Vinorelbine—Urticaria—Epirubicin—thyroid cancer	7.85e-05	0.000575	CcSEcCtD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.83e-05	0.00287	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.83e-05	0.00287	CbGpPWpGaD
Vinorelbine—Constipation—Doxorubicin—thyroid cancer	7.82e-05	0.000573	CcSEcCtD
Vinorelbine—Pain—Doxorubicin—thyroid cancer	7.82e-05	0.000573	CcSEcCtD
Vinorelbine—Abdominal pain—Epirubicin—thyroid cancer	7.81e-05	0.000572	CcSEcCtD
Vinorelbine—Body temperature increased—Epirubicin—thyroid cancer	7.81e-05	0.000572	CcSEcCtD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.73e-05	0.00283	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDK1—thyroid cancer	7.66e-05	0.0028	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.56e-05	0.00277	CbGpPWpGaD
Vinorelbine—Feeling abnormal—Doxorubicin—thyroid cancer	7.53e-05	0.000552	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Doxorubicin—thyroid cancer	7.48e-05	0.000548	CcSEcCtD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.32e-05	0.00268	CbGpPWpGaD
Vinorelbine—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	7.29e-05	0.00267	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Epirubicin—thyroid cancer	7.28e-05	0.000533	CcSEcCtD
Vinorelbine—Urticaria—Doxorubicin—thyroid cancer	7.26e-05	0.000532	CcSEcCtD
Vinorelbine—Body temperature increased—Doxorubicin—thyroid cancer	7.23e-05	0.00053	CcSEcCtD
Vinorelbine—Abdominal pain—Doxorubicin—thyroid cancer	7.23e-05	0.00053	CcSEcCtD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.16e-05	0.00262	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDK1—thyroid cancer	7.09e-05	0.0026	CbGpPWpGaD
Vinorelbine—Asthenia—Epirubicin—thyroid cancer	7.09e-05	0.000519	CcSEcCtD
Vinorelbine—Pruritus—Epirubicin—thyroid cancer	6.99e-05	0.000512	CcSEcCtD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	6.87e-05	0.00252	CbGpPWpGaD
Vinorelbine—Diarrhoea—Epirubicin—thyroid cancer	6.76e-05	0.000495	CcSEcCtD
Vinorelbine—Hypersensitivity—Doxorubicin—thyroid cancer	6.74e-05	0.000493	CcSEcCtD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.58e-05	0.00241	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.58e-05	0.00241	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	6.57e-05	0.00241	CbGpPWpGaD
Vinorelbine—Asthenia—Doxorubicin—thyroid cancer	6.56e-05	0.000481	CcSEcCtD
Vinorelbine—Dizziness—Epirubicin—thyroid cancer	6.53e-05	0.000479	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDK1—thyroid cancer	6.49e-05	0.00238	CbGpPWpGaD
Vinorelbine—Pruritus—Doxorubicin—thyroid cancer	6.47e-05	0.000474	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.43e-05	0.00236	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.35e-05	0.00233	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDK1—thyroid cancer	6.34e-05	0.00232	CbGpPWpGaD
Vinorelbine—Vomiting—Epirubicin—thyroid cancer	6.28e-05	0.00046	CcSEcCtD
Vinorelbine—Diarrhoea—Doxorubicin—thyroid cancer	6.25e-05	0.000458	CcSEcCtD
Vinorelbine—Rash—Epirubicin—thyroid cancer	6.23e-05	0.000456	CcSEcCtD
Vinorelbine—Dermatitis—Epirubicin—thyroid cancer	6.22e-05	0.000456	CcSEcCtD
Vinorelbine—Headache—Epirubicin—thyroid cancer	6.19e-05	0.000454	CcSEcCtD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.15e-05	0.00225	CbGpPWpGaD
Vinorelbine—Dizziness—Doxorubicin—thyroid cancer	6.05e-05	0.000443	CcSEcCtD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.02e-05	0.0022	CbGpPWpGaD
Vinorelbine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	5.88e-05	0.00215	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.88e-05	0.00215	CbGpPWpGaD
Vinorelbine—Nausea—Epirubicin—thyroid cancer	5.87e-05	0.00043	CcSEcCtD
Vinorelbine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	5.85e-05	0.00214	CbGpPWpGaD
Vinorelbine—Vomiting—Doxorubicin—thyroid cancer	5.81e-05	0.000426	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—CDK1—thyroid cancer	5.8e-05	0.00213	CbGpPWpGaD
Vinorelbine—Rash—Doxorubicin—thyroid cancer	5.76e-05	0.000422	CcSEcCtD
Vinorelbine—Dermatitis—Doxorubicin—thyroid cancer	5.76e-05	0.000422	CcSEcCtD
Vinorelbine—Headache—Doxorubicin—thyroid cancer	5.73e-05	0.00042	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—TERT—thyroid cancer	5.52e-05	0.00202	CbGpPWpGaD
Vinorelbine—Nausea—Doxorubicin—thyroid cancer	5.43e-05	0.000398	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.4e-05	0.00198	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.94e-05	0.00181	CbGpPWpGaD
Vinorelbine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	4.77e-05	0.00175	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TERT—thyroid cancer	4.57e-05	0.00167	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TERT—thyroid cancer	4.18e-05	0.00153	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—RXRA—thyroid cancer	3.87e-05	0.00142	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	3.78e-05	0.00139	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CCND1—thyroid cancer	3.57e-05	0.00131	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CCND1—thyroid cancer	3.19e-05	0.00117	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—MINPP1—thyroid cancer	3.02e-05	0.00111	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CCND1—thyroid cancer	2.96e-05	0.00108	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—MINPP1—thyroid cancer	2.85e-05	0.00104	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CCND1—thyroid cancer	2.7e-05	0.00099	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CCND1—thyroid cancer	2.64e-05	0.000968	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NDUFA13—thyroid cancer	2.57e-05	0.000941	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	2.53e-05	0.000928	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NDUFA13—thyroid cancer	2.42e-05	0.000887	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CCND1—thyroid cancer	2.42e-05	0.000885	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CHST14—thyroid cancer	2.41e-05	0.000885	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	2.39e-05	0.000874	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	2.39e-05	0.000874	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.35e-05	0.00086	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CHST14—thyroid cancer	2.28e-05	0.000834	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	2.21e-05	0.000809	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TP53—thyroid cancer	2.1e-05	0.00077	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HPGD—thyroid cancer	1.95e-05	0.000713	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	1.88e-05	0.000688	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—MINPP1—thyroid cancer	1.86e-05	0.000682	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HPGD—thyroid cancer	1.83e-05	0.000672	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.79e-05	0.000655	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TP53—thyroid cancer	1.74e-05	0.000638	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.7e-05	0.000622	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.64e-05	0.0006	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TP53—thyroid cancer	1.59e-05	0.000583	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	1.58e-05	0.00058	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.5e-05	0.00055	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CHST14—thyroid cancer	1.49e-05	0.000545	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.26e-05	0.000461	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HPGD—thyroid cancer	1.2e-05	0.000439	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—TPR—thyroid cancer	1.12e-05	0.00041	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.12e-05	0.000409	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.1e-05	0.000403	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—TPR—thyroid cancer	1.05e-05	0.000386	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.04e-05	0.00038	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	9.44e-06	0.000346	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SLC5A5—thyroid cancer	8.37e-06	0.000307	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	7.89e-06	0.000289	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—RXRA—thyroid cancer	7.03e-06	0.000258	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TPR—thyroid cancer	6.89e-06	0.000252	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	6.78e-06	0.000248	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—RXRA—thyroid cancer	6.63e-06	0.000243	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	5.16e-06	0.000189	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PPARG—thyroid cancer	4.44e-06	0.000163	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—RXRA—thyroid cancer	4.33e-06	0.000159	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PPARG—thyroid cancer	4.18e-06	0.000153	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTGS2—thyroid cancer	3.49e-06	0.000128	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTGS2—thyroid cancer	3.29e-06	0.000121	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTEN—thyroid cancer	3.05e-06	0.000112	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTEN—thyroid cancer	2.87e-06	0.000105	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PPARG—thyroid cancer	2.74e-06	0.0001	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTGS2—thyroid cancer	2.15e-06	7.88e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTEN—thyroid cancer	1.88e-06	6.87e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—AKT1—thyroid cancer	1.76e-06	6.43e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—AKT1—thyroid cancer	1.65e-06	6.06e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—AKT1—thyroid cancer	1.08e-06	3.96e-05	CbGpPWpGaD
